Belvedere Trading »

Outlook Therapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2026-06-30 $73k 46k 1.59

More positions owned by Belvedere Trading

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Micron Technology (MU)
Advanced Micro Devices (AMD)
Sandisk Corp (SNDK)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold SHS (GLD)
Intel Corporation (INTC)

View all positions for Belvedere Trading

Top funds holding Outlook Therapeutics

Armistice Capital
Vanguard Capital Management
Gilpin Wealth Management
Geode Capital Management
BlackRock
Warberg Asset Management
Renaissance Technologies
Connective Capital Management
Citadel Advisors
Susquehanna International
Vanguard Fiduciary Trust
State Street Corporation
UBS Group
Simplex Trading
Group One Trading

View all funds holding Outlook Therapeutics